![](/img/cover-not-exists.png)
A Phase I Study of Intravenous LBH589, a Novel Cinnamic Hydroxamic Acid Analogue Histone Deacetylase Inhibitor, in Patients with Refractory Hematologic Malignancies
Giles, F., Fischer, T., Cortes, J., Garcia-Manero, G., Beck, J., Ravandi, F., Masson, E., Rae, P., Laird, G., Sharma, S., Kantarjian, H., Dugan, M., Albitar, M., Bhalla, K.Volume:
12
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-06-0511
Date:
August, 2006
File:
PDF, 442 KB
english, 2006